Treatment of nausea and vomiting caused by cancer chemotherapy
- 31 December 1982
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Comparative Trial of the Antiemetic Effects of THC and HaloperidolThe Journal of Clinical Pharmacology, 1981
- Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral AdministrationThe Journal of Clinical Pharmacology, 1981
- Antiemetic Effect of Intramuscular Levonantradol in Patients Receiving Anticancer ChemotherapyThe Journal of Clinical Pharmacology, 1981
- Specific antiemetics for specific cancer chemotherapeutic agents: Haloperidol versus benzquinamideCancer, 1981
- Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesisArchives of internal medicine (1960), 1980
- Antiemetics in Patients Receiving Chemotherapy for CancerNew England Journal of Medicine, 1980
- Superiority of Nabilone over Prochlorperazine as an Antiemetic in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1979
- Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1975
- A Controlled Clinical Evaluation of Antiemetic DrugsJAMA, 1963